key: cord-0317781-pb8uxzui
authors: Bibby, Jack A.; Agarwal, Divyansh; Freiwald, Tilo; Kunz, Natalia; Merle, Nicolas S.; West, Erin E.; Larochelle, Andre; Chinian, Fariba; Mukherjee, Somabha; Afzali, Behdad; Kemper, Claudia; Zhang, Nancy R.
title: Systematic Single Cell Pathway Analysis (SCPA) reveals novel pathways engaged during early T cell activation
date: 2022-02-10
journal: bioRxiv
DOI: 10.1101/2022.02.07.478807
sha: a93e3cbaaea965f8981240a18a6c76d365906d14
doc_id: 317781
cord_uid: pb8uxzui

Next generation sequencing technologies have revolutionized the study of T cell biology, capturing previously unrecognized diversity in cellular states and functions. Pathway analysis is a key analytical stage in the interpretation of such transcriptomic data, providing a powerful method for detecting alterations in important biological processes. Current pathway analysis tools are built on models developed for bulk-RNA sequencing, limiting their effectiveness when applied to more complex single cell RNA-sequencing (scRNA-seq) datasets. We recently developed a sensitive and distribution-free statistical framework for multisample distribution testing, which we implement here in the open-source R package Single Cell Pathway Analysis (SCPA). After demonstrating the effectiveness of SCPA over commonly used methods, we generate a scRNA-seq T cell dataset and characterize pathway activity over early cellular activation and between T cell populations. This revealed unexpected regulatory pathways in T cells, such as an intrinsic type I interferon system regulating T cell survival and a reliance on arachidonic acid metabolism throughout T cell activation. A systems level characterization of pathway activity in T cells across multiple human tissues also revealed alpha defensin expression as a hallmark of bone marrow derived T cells. Overall, our work here provides a widely applicable tool for single cell pathway analysis, and highlights unexpected regulatory mechanisms of T cells using a novel T cell dataset.

Next generation sequencing technologies have revolutionized the study of T cell biology, capturing previously unrecognized diversity in cellular states and functions. Pathway analysis is a key analytical stage in the interpretation of such transcriptomic data, providing a powerful method for detecting alterations in important biological processes. Current pathway analysis tools are built on models 30 developed for bulk-RNA sequencing, limiting their effectiveness when applied to more complex single cell RNA-sequencing (scRNA-seq) datasets. We recently developed a sensitive and distribution-free statistical framework for multisample distribution testing, which we implement here in the open-source R package Single Cell Pathway Analysis (SCPA). After demonstrating the effectiveness of SCPA over commonly used methods, we generate a scRNA-seq T cell dataset and characterize pathway activity 35 over early cellular activation and between T cell populations. This revealed unexpected regulatory pathways in T cells, such as an intrinsic type I interferon system regulating T cell survival and a reliance on arachidonic acid metabolism throughout T cell activation. A systems level characterization of pathway activity in T cells across multiple human tissues also revealed alpha defensin expression as a hallmark of bone marrow derived T cells. Overall, our work here provides a widely applicable tool

Dysregulation of T cell responses is a hallmark of a large spectrum human disorders, including autoimmunity, cancer and infectious diseases (Kumar et al., 2018) . Dissecting the molecular events that underly T cell activation, lineage specification and effector function is therefore paramount to the therapeutic targeting of T cell-mediated disease. The advent of transcriptomics, and particularly single 55 cell RNA sequencing (scRNA-seq), has provided the opportunity to link large transcriptional networks to specific cellular activation states and biological functions (Nayak and Hasija, 2021) . Although gene level changes upon T cell activation and/or lineage induction have been well studied, systematic pathway level analyses of T cell populations are lacking. Given the power of pathway analysis to uncover specific biological processes in sequencing data, a systems level analysis of pathway activity 60 applied to many T cell lineages and across stimulation conditions provides the opportunity to reveal novel and key regulatory pathways.

Many approaches have been developed that attempt to untangle the complexity of scRNA-seq data, such as methods for integration (Hie et al., 2019; Stuart et al., 2019; Tran et al., 2020; Welch et al., 65 2019), trajectory inference (Saelens et al., 2019; Street et al., 2018; Wolf et al., 2019) , and dimensionality reduction (McInnes et al., 2008; van der Maaten and Hinton, 2008) . This being said, biological pathway analysis methods are uniquely underdeveloped. Current approaches rely on models from bulk RNA-sequencing, wherein the central focus is on the quantification of signals from individual genes to generate an enrichment or overrepresentation score (Huang da et al., 2009;  70 Kuleshov et al., 2016; Ma et al., 2020; Subramanian et al., 2005) . These methods are based on the assumption that enrichment of a given gene set is the most meaningful statistic when understanding pathway importance. However, these approaches significantly under-utilize the information in the multivariate distribution that a pathway can exhibit in single cell data. Moreover, conventional pathway analysis methods rely on the input of a filtered list of differentially expressed genes (e.g. DAVID, 75 Enrichr) and/or are all currently limited to two-sample comparisons (e.g. GSEA). This means that not only are large quantities of potentially relevant data discarded or ignored, but also tracking pathways over more complex experimental designs, such as multiple time points, is difficult to achieve in a robust way. Therefore, methods that can utilize the multivariate complexity and increasingly multisample design of scRNA-seq studies provide the potential for a more nuanced understanding of 80 gene set behavior.

Here we present Single Cell Pathway Analysis (SCPA), an open-source R package for pathway analysis, and apply it to characterize pathway activity over early T cell activation. SCPA is built around a graph-based nonparametric statistical model (Mukherjee et al., 2020 ) that aims to fully 85 capture the multivariate complexity of single cell data without imposing parametric assumptions on the gene expression distribution. This represents a fundamentally different approach to pathway analysis, whereby gene set activity or perturbation is primarily understood as a change in the multivariate distribution of a given pathway. To gain insights into gene set dynamics underlying early and apply SCPA, uncovering unexpected pathway signatures across time and between T cell populations. This includes revealing an intrinsic IFN pathway that maintains T cell survival upon stimulation, and demonstrating T cell reliance on arachidonic acid metabolism for effective cellular activation and cytokine production. We also perform a systems level characterization of pathway activity across multiple tissue sites to reveal tissue specific features of T cells. In carrying out this 95 analysis, we highlight multiple features of SCPA, including classical two-sample comparisons, multisample pathway analysis, and tracking gene set perturbations over a pseudotime trajectory.

Finally, we demonstrate the scalability of SCPA and its ability to comprehensively characterize pathway level changes across multiple conditions. Overall, we present a user-friendly and highly sensitive tool for pathway analysis in scRNA-seq data along with several new insights into the gene 100 set changes driving early human T cell activation. All documentation and tutorials for SCPA can be found at https://jackbibby1.github.io/SCPA.

We recently developed a nonparametric graph-based statistical framework (Mukherjee et al., 2020) for comparing multivariate distributions in high dimensional data. Here we implement this framework in Single Cell Pathway Analysis (SCPA) ; an open-source R package for the analysis of pathway activity in scRNA-seq data. In brief, this statistic assesses the multivariate, joint distribution of a set of genes belonging to a given pathway to infer whether this pathway is differentially regulated across 110 conditions (see methods). The stepwise outline for SCPA is shown in Figure 1A .

SCPA takes total normalized count matrices from two or more conditions (Figure 1Ai ), preserving the complete dataset. We extract pathway matrices for any given number of pathways, based on manually curated or existing annotation databases ( Figure 1Aii ). Next, based on the joint distribution 115 for all the genes of a given pathway, cells are paired based on optimal matching in the multidimensional space (Figure 1Aiii) , where the number of dimensions is derived from the number of genes. Whether cell pairings occur between cells belonging to the same or different condition determines whether that pathway is differentially distributed or not. For instance, a high number of within-sample matches for a given condition suggests differential distribution of a pathway (left side 120 Figure 1Aiii ). Conversely, many inter-sample matches would suggest that a pathway is not differentially distributed across the groups or conditions (right side Figure 1Aiii ). This analysis provides a statistic, here termed the Q value, which measures the size of distribution change for a given pathway and can be used for the ranking of pathways in order of biological relevance ( Figure   1Aiv ). This method therefore provides a fundamentally different definition of pathway activity when 125 compared to current tools that typically rely on enrichment of overrepresentation of genes in a given pathway. By design, this method is robust to outliers and is shift-and scale-invariant, i.e. the Q value does not change if the expression values of all genes in a given pathway were scaled up or shifted by a constant factor.

Before using SCPA to analyze T cell biology, we first benchmarked the sensitivity and accuracy of SCPA against commonly used pathway analysis tools; notably DAVID and Enrichr that use differentially expressed genes as an input, and GSEA that uses total count matrices as an input ( Figure 1B ). We analyzed four publicly available scRNA-seq datasets generated from mock or virally infectedeither influenza or SARS-CoVcell lines. This allowed us to define positive controls for 135 expected virus-induced gene signatures in a dataset, and then quantify the ability of different pathway analysis methods to detect these expected viral signatures. For the analysis, we used the GO Biological Process gene sets, given that they contain a large range of cellular pathways, and within this, a large range of viral signatures (see methods).

We first quantified how many viral related pathways were detected as differentially regulated using each method. We found that SCPA outperformed analytical tools that utilize lists of differentially Figure 1. SCPA provides a sensitive and accurate reflection of pathway activity (A) Overview of the methodology implemented in the Single Cell Pathway Analysis (SCPA) R package. SCPA takes count matrices generated from the desired cell populations, generates nested matrices based on the genes of a pathway, and then performs graph based multivariate distribution analysis to assess pathway perturbation. The Q value output produced by SCPA can then be visualized for interpretation. (B) Overview of pathway analysis benchmarking. Briefly, publicly available scRNAseq data (GSE122031, GSE148729, GSE156760) that included cell lines infected with viruses were collated. Pathway analysis was then conducted comparing mock versus infected cell lines with either DAVID, Enrichr, GSEA, or SCPA, using 'GO Biological Process' gene sets. The number of significant viral pathways, and how many viral pathways are present in the top 100 pathways, were then compared across methods. (C) The number of viral pathways reaching significance when comparing mock to virally infected cells, across four publicly available datasets using the indicated method. (D) The number of viral pathways that rank in the top 100 pathways. Dot plot shows the rank of viral pathways relative to all GO Biological Process pathways across methods. The number below each method represents how many viral pathways were identified in the top 100 as mean ± SD. All viral pathways are shown in red, and non-viral pathways are shown in grey.

A B * * ** C SCPA 12 ± 1.8 GSEA 9.5 ± 4.5 Enrichr 8 ± 3.7 DAVID 4.5 ± 2.4 Viral pathways in the top 100 D Pathway expressed genes, detecting significantly more viral signatures in virally infected cells than DAVID and Enrichr. GSEA and SCPA were able to identify larger numbers of significant viral signatures, although SCPA significantly outperformed GSEA, identifying ~30% more significant viral signatures ( Figure   145 1C), demonstrating that SCPA is a highly sensitive method for detecting pathway perturbations in scRNA-seq data. In addition to quantifying the number of significantly altered viral pathways, we also asked where these viral pathways rank relative to other differentially regulated pathways in the analysis. Here, as a measure of methodological accuracy, we expected that viral pathways should rank highly, given that this was the only treatment variable across the two conditions (mock vs 150 infected). To measure this, we assessed how many viral pathways were present within the top 100 significant pathways. Here, SCPA consistently identified a greater number of viral pathways present within the top 100 pathways relative to other methods ( Figure 1D ); on average, SCPA identified 12 viral pathways in the top 100, compared to 9.5, 8, and 4.5 for GSEA, EnrichR, and DAVID respectively.

In sum, we provide a novel package for pathway analysis that is specifically powered to detect pathway perturbations in single cell data, which is both highly sensitive and accurate. SCPA was able to detect more significant viral pathways, and these pathways were also more likely to be present in the top 100 significant pathways when compared to other methods.

Single cell sequencing on sorted and stimulated T cell populations We next utilized a systems level approach with SCPA to understand early signals required for the generation of effective human CD4 + and CD8 + T cell responses. We first purified human naïve and memory CD4 + and CD8 + T cells via magnetic bead enrichment and subsequent FACS sorting, and 165 cells were then either left unstimulated, or stimulated for 12 or 24 hours via anti-CD3 and anti-CD28 antibodies (Supplementary Figure 1) . scRNA-seq was then performed on each T cell population, capturing a total of over 40,000 live cells ( Figure 2A ).

Within the scRNA-seq data generated here, we identified well defined T cell populations, both in the 170 resting and activated states. All samples, populations, and time points identified in the sequencing are depicted in the UMAP projections ( Figure 2B ), proportional fractions of cell populations are shown in Figure 2C , and an unbiased selection of top 7 markers (as sorted by false discovery rate) from each cluster are shown in the corresponding dotplots ( Figure 2D ). All markers for each population can also be found in Supplementary Table 1. 175 Unsupervised clustering identified between 4 to 7 sub-populations within the different samples, which are indicated in the UMAP projections ( Figures 2B-D) . In the naïve populations, both CD4 + and CD8 + T cells contained a relatively homogenous resting population, expressing high levels of quiescence markers (IL7R, KLF2, and PIK3IP1). We also identified natural regulatory T cells (Tregs, expressing 180 FOXP3, IL2RA, and CTLA4) and T effector memory cells re-expressing CD45RA (TEMRA, expressing CCL3, CCL4, GZMB, and IFNG) populations in the CD4 + and CD8 + samples, respectively.

Naïve CD8 + T cells also included two small populations of unidentified cells. Upon stimulation, both CD4 + and CD8 + T cells generated two distinct populations corresponding to early and late phases of naïve T cell activation (left panels, Figure 2B ). These data, in combination with trajectory inference 185 modelling, showed that these activation phases included: 1) early expression of many guanylatebinding proteins alongside IRF1 and IRF4, and 2) subsequent expression of several heat shock proteins, a high number of metabolic genes, and effector molecules such as TNF (Supplementary 

As anticipated, circulating CD4 + and CD8 + T cell memory populations were less homogenous than circulating naive T cells, clustering into 6 and 7 sub-populations respectively. Clusters of effector cells were evident in resting and activated memory T cells. In memory CD4 + T cells, we identified T central memory (Tcm), T helper 1 (Th1), Th2, T cells with a high expression of CD69 and IL2 (here termed Teff), and Tregs, based on their canonical markers shown in Figure 2D 

Overall, this analysis identifies well resolved T cell populations, with cell types being stratified by canonical markers. These data therefore provided a resource for characterization of pathway level transcriptomic signatures through early activation, and across a range of human CD4 + and CD8 + T cell populations, as detailed below.

We next applied SCPA to map gene set dynamics throughout T cell activation. To gain a global view of pathway activity within each of the four major T cell populations, we first used the multisample capability of SCPAa technique not possible using current methodsto characterize pathway distributions over the three time points simultaneously for each sorted population (0, 12, and 24 hours (B) Heatmap representation of pathway perturbations generated from the comparisons outlined in (A), with classifications of core pathways into broad categories. The pathways from the topmost cluster (k-means clustering) were manually categorized into broad pathway classes, and the frequency of each class is visualized in the bar plot. (C) Boxplots representing the extent of distribution changes, per pathway, for all 1790 pathways across cell types and stimulation. (D) Heatmap showing FDR values of specific cytokines within the 'cytokine response' class derived from core pathways. 'General' refers to cytokine response gene sets that do not mention a specific cytokine e.g. 'cytokine signaling'. (E) Ranking of all pathway Qvals in naïve CD4 + T cells across activation. Interferon (IFN) pathways are highlighted in red (F) Heatmap representation of interferon response gene expression with genes taken from the 'Reactome interferon signaling' gene set. (G) qPCR for IFNA genes in CD4 + T cells after stimulation with αCD3+ αCD28 for the indicated time with 0hr representing unstimulated cells. Data are relative to RPL7 as an internal reference, calculated as 2 -Δct . Ct values represent the mean over 4 donors ± sd in the 0hr condition (H) IFNα measured in the supernatant of CD4 + T cells after stimulation with αCD3+ αCD28 for the indicated time. 0hr represents unstimulated cells, and red dotted line represents the detection limit (I-J) CRISPR-cas9 mediated deletion of IFNα in CD4 + T cells, showing IFN editing efficiency in (I) and flow cytometry analysis of cell viability after IFNα knockdown in CD4 + T cells (J). CD4 + T cells were isolated, and CRISPR mediated knockdown of IFNα was performed. Cells were then stimulated with αCD3+ αCD28 for 24 hours before analysis by flow cytometry. (K) Viability staining of splenic CD4 + T cells from wild type (WT) or Ifnar1 -/mice. CD4 + T cells were purified and stimulated with anti-CD3 + anti-CD28 for the indicated time before assessment of viability. Embedded panel shows representative live-dead staining taken from the 48hr time point, n = 3 mice per genotype (L) Heatmap representation of STAT1 target gene expression over naïve CD4 + T cell activation. STAT1 targets, taken from the transcription factor targets available on MSigDB were plotted over a trajectory of naïve CD4+ T cell activation. Trajectory inference model calculated using slingshot is shown in supplementary figure 2A. for naïve CD4 + , memory CD4 + , naïve CD8 + , and memory CD8 + populations, Figure 3A ). We used a comprehensive gene set list that included all pathways from the Hallmark, Reactome, and KEGG databases from MSigDB, comprising 1790 pathways in total (Supplementary Table 2 ). Utilizing this gene set list, we identified a set of 'core pathways defined as common gene sets showing significant activity in response to stimulation across all cell types ( Figure 3B ). After categorizing these gene sets 225 into broad classes, the most abundant pathway classes were, as expected, those involved in response to stimuli, including cell signaling, cell cycle, cytokine response, metabolism, and transcription ( Figure 3B ). In addition to this core signature, we also observed a cluster of pathways that typically showed greater activity in memory T cells versus naïve populations upon stimulation, such as unfolded protein response and autophagy (Supplementary Figure 4) . Further, certain 230 pathways showed little or no change in distribution upon activation, including pathways not expected to change, such as digestion (Supplementary Figure 4) . Interestingly, across pathways, memory cells showed a larger magnitude of change in their pathway distribution upon activation, suggesting that memory populations undergo a more extensive remodeling of their transcriptional profile, per pathway, relative to naïve cells ( Figure 3C ). Overall, we validate the multisample capability of SCPA 235 in accurately recapitulating known core pathway signatures of T cell activation over time.

To more deeply understand these global profiles, we next looked for enrichment of specific signatures in the core pathways. As cell signaling and cell cycle events have been well characterized upon T cell activation, we chose to investigate cytokine response signatures. Within this pathway class we noted 240 a presence of interferon (IFN) response gene sets across all four naïve and memory CD4 + and CD8 + T cell populations ( Figure 3D ). To further explore this, we focused on CD4 + T cells to assess if a particular cell type was driving this interferon response signature, and whether this pathway was being positively or negatively regulated upon activation. We used SCPA to conduct a two-sample comparison of each cell type, comparing 0hr to 24hr activated populations identified in the UMAP 245 clustering ( Figure 2B ). Unexpectedly, IFN response genes were broadly enriched after activation in all CD4 + T cell populations (Supplementary Figure 5A ). Taking naïve CD4 + T cells as an example, IFN response pathways also ranked amongst the most significantly altered pathways upon T cell activation ( Figure 3E ), suggesting that IFN signaling is a central component of T cell activation.

However, we observed that T cells induce a distinct IFN response signature, which is dependent on 

NUP genes ( Figure 3F ). These data suggest that, even though all CD4 + T cells induce an interferon response signature upon activation, these signatures diverge depending on Treg versus non-Treg cell identity.

As these were sorted T cell populations, maintained in media without polarizing cytokines, and naïve 260 CD4 + T cells do not produce type II IFNG transcript or IFN protein (Supplementary Figure 5B -C), these data suggested possible involvement of a cell-intrinsic type I interferon signaling. The significant overlap of genes between type I and type II response gene sets makes it difficult to define the exact interferon subtype driving the observed signature, but the above analysis with SCPA did reveal type I interferon signatures in both naïve and memory T cells (Supplementary Figure 5D ). Although it is 265 known that type I IFNs, IFN and IFN , regulate CD4 + and CD8 + T cell cytokine production, proliferation, survival, and/or migration (Crouse et al., 2015; Marrack et al., 1999) , T cells themselves are not considered to be a source of type I IFNs. Rather, it is thought that type I IFNs are largely derived from innate immune lineages during viral infections (Ivashkiv and Donlin, 2014) . Therefore,

we explored the possibility that T cells may produce their own type I IFN upon stimulation. Likely

given the relatively low sensitivity of scRNA-seq, we did not detect IFNA expression in our dataset.

We therefore analyzed three RNA-seq/microarray datasets from the literature for expression of IFNA genes in CD4 + T cells either ex vivo or after in vitro activation. Here we observed low but consistent levels of IFNA expression in both resting and activated T cells, with the most consistent expression of IFNA4, IFNA7, IFNA17, and IFNA21 across datasets (Supplementary Figure 5E ). Given the 275 increased sensitivity of qPCR over RNA-sequencing methods, we next measured expression of these four IFNA genes upon T cell activation using qPCR. We observed robust expression of IFNA1/13/21

in CD4 + T cells and low levels of IFNA17, whereas we detected little or no expression of IFNA4, IFNA7 ( Figure 3G ). Additionally, and in agreement with our qPCR data, we noted that CD4 + T cells secrete low levels of IFN protein upon stimulation at around 12-24 hours post activation with anti-

CD3 and anti-CD28 ( Figure 3H , Supplementary Figure 6E ).

Given that we observed IFN production by CD4 + T cells, we next asked if an absence of T cellderived IFN resulted in an altered T cell phenotype. We therefore used CRISPR-Cas9 mediated deletion of IFN in purified CD4 + T cells, targeting multiple IFNA genes, afforded by the high 285 sequence similarity (see methods, Supplementary Figure Figure 5J ). Together these data indicate that T cells require IFN to maintain survival 295 upon activation and that they possess the ability to produce IFN in an autocrine/paracrine fashion.

After cytokine response pathways, our analysis with SCPA demonstrated that the gene set class with the next largest distribution change was that of metabolism ( Figure 3B ). Although context-dependent 300 metabolic programs have been linked to specific T cell functions, a systematic assessment of transcriptional metabolic reprogramming in T cells has yet to be done. We therefore sought to characterize the landscape of transcriptional metabolic reprogramming upon T cell activation across comprehensive list of metabolic pathways.

SCPA s unique capability to analyze multiple groups/conditions simultaneously lends itself to novel analyses of pseudotime trajectories with multiple intermediate populations.

To exhibit this, we first reconstructed the trajectory of naïve CD4 + T cell activation, using slingshot (Street et al., 2018) , to recapitulate the progression of these cells through activation phases. To generate distinct populations across activation, we split this trajectory across pseudotime into multiple nodes (using milestones as 310 explained in methods, Figure 4A ). (Chapman et al., 2020) . Interestingly, metabolic change, both relating to magnitude and pathway specificity in naïve T cells, was very similar to that seen upon memory T cell activation, suggesting a similar utilization of metabolic pathways in both populations (Supplementary Figure 6C) .

Conversely, perturbations in activity of other pathways, such as linoleic acid and nitrogen metabolism,

were comparatively modest following T cell activation, possibly indicating that these pathways play a less significant role in the biology of activated T cells or that they are not regulated principally through transcription. Indeed, the pathway expression of linoleic acid metabolism over pseudotime is substantially different from glycolysis ( Figure 4C ). Additionally, we discovered several metabolic pathways that have so far not been linked as intrinsic regulators of T cell biology, such as propanoate 330 metabolism and arachidonic acid metabolism ( Figure 4B ). Although undergoing smaller changes relative to pathways such as glycolysis and OXPHOS, these pathways showed statistically significant changes in pathway perturbation, possibly suggestive an important role in T cell function.

As an internal control of the pseudotime pathway analysis, we correlated the results above with a 335 more classical 2-sample comparison using our real time data. We compared 0hr resting cells, to Naïve CD4 + Figure 4 . Arachidonic acid metabolism regulates CD4 + T cell activation (A) Trajectory analysis of naïve CD4 + T cell activation. Naïve CD4 + T cells were subjected to trajectory inference modelling using slingshot, and subsequently split into nodes across the trajectory using dyno (see methods).

(B) SCPA analysis outline (above) and output (below) using a manually curated list of metabolic pathways across pseudotime populations. 186 manually curated metabolic pathways were used with SCPA to categorize metabolic reprogramming across the four identified activation phases in native CD4 + T cell activation. Figure 2B ). In line with our pseudotime trajectory pathway analysis ( Figure 4B) , OXPHOS, glycolysis, and amino acid metabolism pathways were highly significant and also positively enriched in activated cells ( Figure 4D , Supplementary Figure 6D) . Interestingly, and an important unique 340 aspect of our tool, many pathways showed significant changes in multivariate distribution, but no overall enrichment ( Figure 4D , blue dots). Thus, these pathways show changes in transcriptional regulation detected by SCPA, that are independent of overall pathway enrichment. One such highly significant pathway showing this trend, outside of metabolic pathways already defined as important to T cell function, was arachidonic acid metabolism. We compared this finding to GSEA to see if such a 345 signature would be missed using classical approaches, and indeed, given the lack of pathway enrichment, arachidonic acid metabolism was not significant, ranking poorly at both 12 (FDR q-val = 0.7) and 24 (FDR q-val = 0.4) hours after stimulation ( Figure 4E, Supplementary Figure 6E ). Given that the intrinsic regulation of arachidonic acid metabolism has not been described in T cells, we sought to confirm our finding with exploratory functional experiments. We noted upregulation of key Having analyzed the transcriptional regulation of metabolic pathways upon activation, we next decided to investigate how metabolic pathways are maintained across CD4 + T cell differentiation.

Although it is known that naïve and memory CD4 + T cells maintain different standards of glycolysis Figure 6F) . Second, we observed substantial differences between resting memory T cell subtypes, specifically effector subsets (Th1, Th2, and Tregs) and Tcm cells, with Tcm cells showing a broadly similar profile to resting naïve T cells ( Figure 4K ). Highlighting specifics, looking at topmost differentially regulated pathway, amino acid metabolism, we saw that a defining 380 feature of Tcm vs Th1 cells is their relative expression of ribosomal versus proteasomal genes ( Figure   4L ). Here Tcm cells were defined by relatively high expression of ribosomal subunit (RPL/RPS) genes whereas Th1 cells showed higher levels of proteosome subunit (PSM) genes. Furthermore Th1 cells were characterized by higher expression of genes regulating polyamine synthesis (OAZ1, ODC1, SRM), asparagine synthesis (ASNS), and amino acid transport (SLC3A2, SLC7A5), suggesting that

Tcm and Th1 cells differ significantly in their utilization and synthesis of amino acids ( Figure 4M ).

Taken together, these data demonstrate that quiescent Th1, Th2, and Treg populations differ significantly in their transcriptional regulation across a wide range of metabolic pathways when compared to Tcm and resting naïve CD4 + T cells ( Figure 4N ).

Overall, these data demonstrate the multisample pseudotime capability of SCPA and highlight the power of a systematic approach identify new pathways underlying metabolic regulation of cellular activity.

Having characterized T cell pathways in an in vitro setting, we next aimed to understand how pathways are regulated when T cells migrate into tissue. For this, we analyzed a dataset from Szabo conditions. For example, unstimulated CD8 + Tem cells from the blood were compared to unstimulated CD8 + Tem cells from the lung, lymph node, and bone marrow, and so on ( Figure 5C ).

We were therefore able to characterize the changes in pathway activity when T cells are present in each tissue, as well as how they respond to stimulation. Globally, we observed that T cells present in 410 the lung show the largest alteration in pathway activity compared to those from the lymph node and bone marrow ( Figure 5D ). Interestingly, a large source of variance within the data originated from the tissue site T cells were derived from, in addition to stimulation, suggesting that tissue migration imprints significant altered transcriptional profiles on cells even prior to activation ( Figure 5E ). Figure 7B) . Furthermore, T cells from the tissue also showed high variance in arachidonic acid-derived prostaglandin synthesis and regulation, largely driven by expression of annexin family genes (ANXA1-2) that inhibit PLA2 activity, but also S100A10 and S100A6 that 425 regulate annexin activity (Supplementary Figure 7C) . However, the pathway with the most variable effect size was, unexpectedly, involved in antimicrobial peptide production. In assessing expression of genes from this pathway, this signature was driven by alpha defensin molecules DEFA1 and DEFA3, whose expression is currently thought to be limited mainly to neutrophils and mucosal epithelia.

Moreover, assessing tissue specificity, this signature was exclusive to bone marrow-derived T cells,

suggesting a tightly controlled tissue specific feature of T cells. To further validate our finding, we analyzed a previously published microarray dataset from Okhrimenko et al. (2014) of T cells sorted from the bone marrow and blood of healthy donors. In agreement with our data, we saw significantly increased transcript expression of DEFA1/3 in T cells from the bone marrow when compared to the blood ( Figure 5H ). Furthermore, to confirm this signature at the protein level, we sourced bone 435 marrow of healthy human donors and compared DEFA1 expression to blood derived T cells from age and sex matched controls. DEFA1 was expressed almost exclusively in CD3 + T cells from the bone marrow when compared to CD3 + T cells from the blood (Figures 5I-J) . These data therefore uncover a novel feature of bone marrow derived T cells; namely the expression of alpha defensin molecules.

In sum, we generate a global map of pathway activity in tissue derived T cells, identify a broad perturbation of pathway activity in T cells from the tissue, especially in lung derived T cells, and further discover a previously unrecognized alpha defensin expression profile in T cells from the bone marrow.

Here we introduced SCPA as a novel and effective approach to pathway analysis in scRNA-seq data.

We utilized SCPA to systematically map pathway activity in T cells across time, between T cell populations, and across tissues, uncovering novel regulatory mechanisms of T cells.

Our approach to pathway analysis described in this work harnesses a statistical framework that considers changes in the multivariate distribution of all the genes of a given pathway as the primary statistic for judging biological relevance. This approach is highly robust, and does not depend on parametric assumptions on the gene expression distribution. By design, it is sensitive to distribution 455 changes (Mukherjee et al., 2020 ) that would otherwise be missed using enrichment profiles. As an illustration, when considering a situation in comparing healthy and disease samples, whereby a pathway shows significant changes in its multivariate distribution but lacks enrichment of pathway genes in any given sample; this would still indicate substantial pathway perturbation. However, given the lack of mean differences, this would not be identified using current enrichment methods. We 460 highlighted this unique feature of SCPA when we identified the requirement of cell-intrinsic arachidonic acid metabolism for T cell activation and effector function, which was not considered significant by GSEA. Of note, we found that many additional pathways demonstrated similar profiles (e.g. Figure 4D ), which provides candidate pathways for future work. Further still, even though our statistical framework assesses distribution changes, gene sets that do show enrichment also 465 necessarily show alterations in multivariate distribution, meaning that SCPA captures both aspects of pathway activity. This is also likely the reason why SCPA was able to identify a greater number of significant viral pathways when compared to other pathway analysis tools in our benchmarking ( Figure 1 ). We therefore argue that assessing changes in multivariate distribution more accurately reflects what should be considered interesting when addressing pathway level gene signatures.

Employing SCPA to our scRNA-seq resource provided a systems level view of T cell transcriptional regulation upon activation, highlighting a number of interesting signatures. In contrast to current approaches that are largely restricted to two-sample comparisons, SCPA can assess gene set distributions across a multisample input simultaneously and is well suited to addressing experimental 475 designs with greater than two conditions. Here we used SCPA over such a multisample design, assessing three early time points across T cell activation. We identified a core set of pathways that are shared upon T cell activation across naïve and memory CD4 + and CD8 + T cells. This led to the discovery of type I IFN signaling as a central transcriptional module in CD4 + T cell populations. T cells are responsive to exogenous IFN (Huber and Farrar, 2011) but are not known to produce IFN 480 themselves. As the design of our T cell activation experiments excluded an exogenous source of IFN , we concluded that the type I IFN signature must be rooted in an autocrine mechanism.

Although limited in scope, our functional experiments supported such an idea as proof-of-principle: we demonstrated IFN secretion upon T cell activation and a dependency on intrinsic IFN for survival, at least in vitro. Indeed, we had previously established such a concept for another cytokine that was 485 thought not to be produced by T cells; namely IL-1 . T cells produce IL-1 in very low amounts, yet intrinsic IL-1 controls the magnitude of Th1 responses (Arbore et al., 2016) and exogenous IL-1 cannot compensate for this function. Though IFN is known to aid T cell survival (Marrack et al., 1999) , a role for T cell-autocrine type I IFN may have previously been overlooked, as human T cells produce also only small quantities of this cytokine ( Figure 3I ). Additionally, Ifna -/mice do not exist,

with IFN targeted studies instead utilizing Ifnar1 -/animals, or depleting classical sources of IFN , such as pDCs, which makes it unsuitable to pinpoint T cell-autocrine IFN functions. Two additional observations we made with regards to IFN biology will be worthy to investigate further. First, our data indicated that T cells produce IFNA with at least some specificity toward IFN21 -though our primers also showed an overlap with IFNA1/13 -and not other IFNA genes including IFNA4, IFNA7 or 495 IFNA17. This is interesting in view the of emerging realization that different type I IFN subtypes can have diverse effects on CD8 + T cell antiviral responses (Dickow et al., 2019) . Furthermore, we showed that while all T cells harbor or acquire a strong IFN pathway signature, the respective gene transcription profiles induced are distinct among T cell subpopulations. We noted a specific demarcation between (memory) Tregs and non-regulatory T cells, suggesting tailored and selective 500 responses downstream of the IFN receptor between lineages of inflammatory and regulatory T cells.

SCPA also highlighted metabolism as a pathway class with large distribution changes upon T cell activation. Although it is well established that all aspects of the T cell life cycle are controlled by metabolic events (Buck et al., 2015) most existing works focus on the analysis of one or a few select 505 metabolic pathways in a given study. Here we provided a means for comprehensive pathway analyses of scRNA-seq data that can distinguish changes in the landscape of metabolic pathways upon cell activation, over time, or across stimulation conditions. Across naïve CD4 + T cell activation we confirmed that fundamental metabolic pathways, such as glycolysis and OXPHOS, featured prominently as expected. However, we also uncovered several metabolic pathways previously not 510 associated with T cell metabolism. One such pathway was that of arachidonic acid metabolism, which we showed was necessary for proper T cell activation and IFN /IL-10 production. Though we did not define the exact mechanism of this regulation, downstream metabolites of arachidonic acid generated by immune cells, including as prostaglandins, prostacyclins, and leukotrienes, impact T cell function at several levels (Maseda et al., 2019) . Much of the literature on arachidonic acid metabolite 515 production focuses on innate immune cells, though our work here shows that T cells produce and utilize arachidonic acid via phospholipase A2 to induce proper T cell activation in vitro. In addition, we also observed upregulation of genes involved in the inhibition of PLA2 (ANXA and S100 family members) in T cells from the tissue, suggesting that inhibition of arachidonic acid metabolism in vivo could contribute towards confining T cell activation in vivo. Indeed, a recent paper has demonstrated 520 that T cells from patients with rheumatoid arthritis are hyper-responsive to exogenous arachidonic acid, resulting in increased calcium flux and pERK signaling (Ye et al., 2021) , hinting that dysregulation of this pathway in T cells could play a role in inflammatory disease.

In addition to mapping metabolic pathways across T cell activation, we compared metabolic 525 transcription across quiescent T cell subpopulations and demonstrated that memory CD4 + T cell lineages maintain different levels of metabolic poise. We found that whilst Tcm cells display a broadly similar metabolic profile relative to naïve T cells, quiescent Th1 and Th2 cells maintain altered levels of metabolic transcription across a broad range of metabolic pathways. Whilst previous work has shown that bulk memory T cells exhibit higher levels of glycolysis and OXPHOS relative to naïve cells 530 (Gubser et al., 2013) , our findings here suggests that this heightened metabolic activity may be predominantly driven by a minority of memory CD4 + T cell subpopulations, rather than memory T cells as a whole. Further, we suggest that the metabolic distinction between naïve and memory T cells may be larger than previously appreciated, noting that a broad range of metabolic pathways outside of glycolysis and OXPHOS were differentially regulated. One such observation was that a number of 535 glycogen-related metabolic pathways were active in CD4 + effector memory populations relative to Tcm cells. The generation of glycogen stores in dendritic cells supports their early effector functions via contributions to glycolytic reprogramming and mitochondrial respiration after toll-like receptor ligation (Thwe et al., 2017) . Further, glycogen breakdown has been shown to support CD8 + T cell memory homeostasis and survival (Ma et al., 2018) . Although speculative at this point, the glycogen 540 signature in effector memory T cells could represent an important component of the heightened metabolic poise that enables these cells to respond rapidly to stimulation. Overall, our work here focused on T cells, though we anticipate similar systematic approaches to immune metabolism using scRNA-seq will reveal important and previously undiscovered aspects of immune regulation across other cell types.

In addition to our in vitro work, we performed a systems level analysis of pathways in ex vivo T cells derived from different tissue sites. This was possible given that SCPA provides a computationally scalable approach to identify pathway signatures in vast amounts of multisample transcriptomic data.

In this, we analyzed around 3000 pathways in 15 cell types across multiple tissues and stimulation 550 conditions. Surprisinglyas it is currently thought that defensin production is mainly restricted to innate immune cells and epithelial cells (Xu and Lu, 2020) -we identified alpha defensin expression, through DEFA1 and DEFA3, as a unique feature of T cells from the bone marrow. To our knowledge, there is no precedent for alpha defensin expression by T cells. Previous work has been unable to detect alpha defensin expression in CD8 + T cells from the blood by mass spectrometry (Mackewicz et 555 al., 2003) , with similar results in two T cell lines (Agerberth et al., 2000) , but did detect alpha defensin in CD3 + T cells, likely coming from the fraction. These findings are in line with our data, suggesting that alpha defensin expression seems to only be upregulated in T cells after migration into the bone marrow, and not in other tissues. We did not uncover the reason for alpha defensin expression in T cells, however, the antimicrobial nature of defensins possibly contributes to 560 general sterility of the bone marrow microenvironment. Nonetheless, the immune regulatory properties of defensins are broad, meaning defensin expression could influence a multitude of processes such as cell migration, cytokine release, and proliferation (Fruitwala et al., 2019; Xu and Lu, 2020) , and future work defining the precise role of T cell derived alpha defensins is required.

In summary, by developing and employing SCPA, we uncovered novel cytokine and metabolic pathways engaged during early T cell stimulation and provided comprehensive global signatures of pathway alterations among distinct T cell subpopulations. Overall, this work outlines the power of systematic approaches to uncover novel regulatory pathways across a wide range of cell types and tissues. Furthermore, though our work here focused on T cells from healthy donors, this approach will 570 be invaluable in characterizing pathway perturbations in a disease setting, generating an unbiased analysis of the relative cell specific dysfunctions contributing to disease pathogenesis, alongside providing therapeutic targets.

Human bulk CD4 + or CD8 + T cells were isolated from PBMCs, obtained from freshly drawn blood after centrifugation using Lymphoprep separation medium (Corning, Vienna, VA) using either the MACS Human CD8 + T cell Isolation Kit ( 

Both wild-type and IFNAR1 -/mice were on a C57BL/6 background, with IFNAR1 -/mice previously described in (REF) . Splenic single cell suspensions were generated, and red blood cells lysed using ACK lysis buffer (Life Technologies). CD4 + T cells were isolated by negative selection using the Stem Cell Technologies EasySep Mouse CD4 + T Cell Isolation Kit (Tukwila, WA), resulting in a CD4 + purity 610 of 95-98%, and a CD3 + purity of ~99%. CD4 + T cells were then plated at 180,000 cells per well in a 96-well plate and activated with plate-bound anti-CD3 (2 g/ml) and soluble anti-CD28 (1 g/ml) for the indicated time before harvesting and staining with near-IR fluorescent reactive dye (Invitrogen).

Cells were harvested after stimulation and viability of cells post activation was measured using the LIVE/DEAD™ Fixable Aqua Dead Cell Stain Kit (Thermo Fisher Scientific). Surface staining of antigen was performed at 4 C for 20 minutes. For intracellular antigens, cells were fixed and permeabilized using the FOXP3/Transcription factor staining kit (eBioscience), and incubated with the appropriate antibody for 1 hour at 4 C. Acquisition of cells was performed using the BD 620 FACSCantoTM II Flow Cytometer and subsequent analysis was performed using FlowJo (v9 or v10).

The clone and dilution of antibodies used for flow cytometry were as follows: CD4-Pacific Blue 

Miltenyi Biotec) following manufacturers instruction.

We prepared single cell transcriptome libraries using the 10xGenomics Chromium Single Cell v3 kit, Supplementary Table 1 .

Scripts for replicating all figures in the paper can be found at 655 https://github.com/jackbibby1/scpa_paper. For pathway analysis, log1p normalized data was extracted from each relevant population and pathways were pulled from the molecular signatures database using the msigdbr package within R. Comparisons were then done using the compare_pathways() function within SCPA using default parameters. Data processing and visualization was then performed using Seurat (Satija et al., 2015) , ggplot2 (Wickham, 2016) ,

ComplexHeatmap (Gu et al., 2016) , and dyno (Saelens et al., 2019) R packages.

3 publicly available datasets were used for comparisons, under the accession numbers: GSE122031, GSE148729, and GSE156760 (containing 2 datasets used here). For Enrichr and DAVID, data were 665 split between mock or virally infected cells, and differentially expressed genes were calculated using the FindMarkers() function within Seurat, using a logFC threshold of 0.4. Differentially expressed genes were then input into DAVID and Enrichr, and results were filtered to include GO Biological Process gene sets. For SCPA and GSEA, data were split by between mock and virally infected cells, cell numbers were downsampled to 500 cells per sample, and then expression files were directly 670 used downstream. GSEA was ran using default parameters: 'phenotype permutation, 'weighted enrichment statistic, Signal2Noise ranking metric, and gene sets with < 15 genes or > 500 genes were excluded. SCPA was ran using default parameters, excluding gene sets with < 15 genes or > 500 genes. Viral gene sets were defined by any pathways containing the string "VIR" in their pathway name, within the GO Biological Process gene set list, and all viral pathways can be found in 675 Supplementary Table 4 .

All scripts for the trajectory inference analysis can be found at https://github.com/jackbibby1/scpa_paper. The R package dyno was used to calculate trajectories 680 and discrete nodes across pseudotime. Briefly, the top 1000 most variable genes were taken from naïve T cells across 0, 12, and 24 hours (after excluding regulatory T cells) and used in the downstream analysis. The naïve CD4 + T cell trajectory was then calculated using the infer_trajectory() function within dyno, using the ti_slingshot() method. Milestones along the trajectory were calculated using the group_onto_nearest_milestones function within dyno. After assignment, cells were then 685 extracted based on their milestone identifier, and these discrete populations were subsequently used for input into SCPA. A list of manually curated 243 metabolic pathways were used for the pseudotime pathway analysis, which can be found in Supplementary Table 3 .

Given K multivariate probability distributions F1, F2, ... , FK, the K-sample problem is to test the hypotheses H0 : F1 = ··· = FK versus H1 : Fs Ft , for some 1 s < t K based on collections of independent observations -1 , , … , -coming from F 1 ,F 2 ,...,F K respectively. In the single cell setting, F s correspond to the tissue samples, and s denote the number of cells sequenced for a given condition K. For example, in this work we are interested in comparing the multivariate distribution of a gene set (corresponding to a particular pathway) across K=3 conditions, F1 (0h), F2 (12h) and F3 (24h), for a given cell type.

Several tests exist for nonparametric testing in the 2-sample framework that are based on the 700 idea of constructing graphs on the pooled sample 1 ∪ ∪ … ∪ , such as nearest neighbor graphs (Henze, 1988; Schilling, 1986) , minimal spanning trees (Friedman and Rafsky, 1979) or graphs based on optimal non-bipartite matching (Rosenbaum, 2005) . Inspired by the latter method and ideas developed in another recent paper (Chen and Friedman, 2017) is distribution free under H0, and exact expressions for the entries of can be computed from a given dataset. Instead of using the exact null distribution of its weak limit, the chi-squared distribution with degrees of freedom can be used for computing the test cut-off. Since is a 720 measure of distance between and , the null hypothesis is rejected when is "sufficiently large", i.e. exceeds a certain null hypothesis p-value cut-off. Additional theoretical details are described and proved in the associated statistical work {Mukherjee, 2020 #6}.

The test statistic above is used to construct the value used in this paper and in scpa for Nucleofection: Up to 10 x 10 6 of freshly isolated human CD4 + T cells were used per electroporation.

Cells were transferred in 1.5 mL Eppendorf tubes and washed twice with PBS 1X (Gibco) to remove all trace of FCS. Immediately before electroporation, cells were resuspended with 10 L of primary cell nucleofection solution (P3 primary Cell 4D-Nucleofector X kit S (Lonza, # V4XP-3032), and mixed 770 with RNP complexes. The mixture cells/RNP complex was then transferred into electroporation strip.

Within 5 minutes, cells were electroporated using "EH-100" pulse on 4D-nucleofectore core unit (Lonza). Immediately after electroporation, 100 L of pre-heated cRPMI + 20 UI/mL IL-2 was carefully added directly into each well of the nucleofection strip, and the strip was placed in tissue culture incubator for 15-30 min to allow for cell recovery. Cells were then transferred into a culture plate, 775 resuspended at 2 x 10 6 / mL in cRPMI + 20 UI/mL IL-2 and incubated at 37 C for 3 days before stimulation. 

2% (Invitrogen, # G401002) for 10 minutes. Bands were revealed with ChemiDocTM Imaging System (BIO-RAD) using SYBR safe filter.

Gene modification was estimated using the following formula:

% gene modification = 100 x (1 -(1 -fraction cleaved) 1/2 ) 800

Supernatants from cultured T cells were harvested and stored at -20 C until analysis. Arachidonic acid measurement was done using the human arachidonic acid ELISA kit (Novus biologicals)

following manufacturer s instructions. Measurement of cytokines was done using the legendplex inflammation panel mix and match (IFN , TNF , IL-10, Biolegend) or VeriKine-HS Human IFN all 805 subtype TCM ELISA (PLB assay science), following manufacturer s instructions.

For analysis of OCR (in pMoles/min) and ECAR (in mpH/min), the Seahorse XF-96 metabolic extracellular flux analyzer was used (Seahorse Bioscience, North Billerica, MA). Naive or memory 

All single cell data generated in the paper is available at [upload data]. We have included all raw files, and processed files containing count tables and annotation information for each sorted population,

and processed R objects for each population. Single cell data using tissue derived T cells was taken from GSE126030. Microarray expression data from bone marrow T cells was taken from GSE50677.

Datasets used in benchmarking was taken from GSE122031, GSE148729, and GSE156760.

Code used to generate all figures in the paper can be found at https://github.com/jackbibby1/scpa_paper. Tutorials and reference documentation for SCPA can be A., C.K., and N.Z., and the project was supervised by C.K. and N.Z.

The authors declare no conflicts of interest (F) IFNα production by CD4 + T cells upon activation. CD4 + T cells were stimulated using anti CD3 + anti CD28 for the indicated time, and cell supernatants were measured for the presence of IFNα (G) Outline of CRISPR protocol. Cells were stimulated using 2ug/ml anti-CD3 + anti-CD28 (H) T7 assay for analysis of CRISPR efficiency. WT band of IFNA is expected at 589, with fragments in the CRISPR-Cas9 edited samples expected to be at: 346, 302, 284, and 240. L = ladder, Scr = scrambled, IFN = IFNA1 CRISPR-Cas9 targeted deletion (I) Average expression of STAT1 targets over naïve T cell activation, calculated through mean gene expression per cell. STAT1 targets were taken from the STAT1_01, STAT1_02, and STAT1_03 gene sets available on MSigDB.

(J) Expression of IFNAR1 and IFNAR2 across T cell subsets. Subsets correspond to those highlighted in the UMAP in Figure 2B . show non significant pathways, gray points show significant pathways with no enrichment, and blue points show significant pathways that also show enrichment.

(E) Gene set enrichment analysis of metabolic pathways in naïve CD4+ T cells. Metabolic pathways in 0hr resting CD4 + T cells were compared to 12hr (left panel) and 24hr (right panel) stimulated CD4+ T cells, with arachidonic acid metabolism highlighted in red.

(F) Number of significantly perturbed metabolic pathways in resting naïve cells versus resting memory population indicated. Significance was classed as a Qval > 5. Percentages indicate the proportion of significant pathways Naïve CD4 + T cells Memory CD4 + T cells ANXA2 S100A10 S100A6

The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte 885 populations

T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4⁺ T cells

T cell metabolism drives immunity

Metabolic coordination of T cell quiescence and activation

A New Graph-Based Two-Sample Test for Multivariate 895 and Object Data

Regulation of antiviral T cell responses by type I interferons

Diverse Immunomodulatory Effects of Individual IFNα Subtypes on Virus-Specific CD8(+) T Cell Responses

The Immune-Metabolic Basis of Effector Memory CD4+ T 905 Cell Function under Hypoxic Conditions

Multivariate Generalizations of the Wald-Wolfowitz and Smirnov Two-Sample Tests

Multifaceted immune functions of 910 human defensins and underlying mechanisms

Complex heatmaps reveal patterns and correlations in multidimensional genomic data

Rapid effector function of memory CD8+ T cells requires an immediate-early glycolytic switch

A Multivariate Two-Sample Test Based on the Number of Nearest Neighbor Type Coincidences

Efficient integration of heterogeneous single-cell transcriptomes using Scanorama

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

Regulation of effector and memory T-cell functions by type I interferon

Regulation of type I interferon responses

Enrichr: a comprehensive gene set enrichment analysis web server 2016 update

Human T Cell Development, Localization, and Function throughout Life

A Pck1-directed glycogen metabolic program regulates formation and maintenance of memory CD8(+) T cells

Integrative differential expression and gene set enrichment analysis using summary statistics for scRNA-seq 940 studies

alpha-Defensins can have anti-HIV activity but are not CD8 cell anti-HIV factors

Type I interferons keep activated T cells 945 alive

Prostaglandin regulation of T cell biology

UMAP: Uniform Manifold Approximation and Projection for Dimension Reduction

Distribution-Free Multisample Tests Based on Optimal Matchings With Applications to Single Cell Genomics

A hitchhiker's guide to single-cell transcriptomics and data analysis pipelines

Human memory T cells from the bone marrow are resting and maintain long-lasting systemic memory

An exact distribution-free test comparing two multivariate 960 distributions based on adjacency

A comparison of single-cell trajectory inference methods

Spatial reconstruction 965 of single-cell gene expression data

Multivariate Two-Sample Tests Based on Nearest Neighbors

Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics

Comprehensive Integration of Single-Cell Data

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

Single-cell transcriptomics of human T cells reveals 980 tissue and activation signatures in health and disease

Cell-Intrinsic Glycogen Metabolism Supports Early Glycolytic Reprogramming Required for Dendritic Cell Immune Responses

A benchmark of batch-effect correction methods for single-cell RNA sequencing data

Visualizing Data using t-SNE

Single-Cell Multi-omic Integration Compares and Contrasts Features of

ggplot2: Elegant Graphics for Data Analysis 995

PAGA: graph abstraction reconciles clustering with trajectory inference through a topology preserving map of single cells

Defensins: A Double-Edged Sword in Host Immunity

Arachidonic acid-regulated calcium signaling in T cells from patients with rheumatoid arthritis promotes synovial inflammation

This work was supported in part by the Intramural Research Program of the NIH, the National Heart, Lung, and Blood Institute (project number zia/hl006223 to C.K., Z99 HL999999 to A.L.), and 5R01-HG006137-07 and 1U2CCA233285-01 to N.R.Z. We thank Howard Young and Julio Valencia for providing the Ifnar1 -/mice used in this study.

Cell culture, sorting, and preparation for single-cell analysis was performed by T.F., C.K., and E.E.W. Seahorse analysis was performed by N.K. and C.K. Bone marrow samples were provided by F.C and